Biotechnology
The Biotechnology industry has a total of 589 stocks, with a combined market cap of $1.24 trillion and total revenue of $113.51 billion.
Market Cap
1.24T
Revenue
113.51B
Profits
-40.29B
PE Ratio
n/a
Profit Margin
-35.49%
Dividend Yield
0.04%
589 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 122.89B | 1.28% | 1,382,970 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.75B | 1.04% | 532,302 | 15.53B |
| 3 | ARGX | argenx SE | 54.05B | 2.78% | 358,791 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 41.95B | 1.98% | 1,952,618 | - |
| 5 | ONC | BeOne Medicines AG | 37.24B | 1.40% | 476,547 | 6.13B |
| 6 | RPRX | Royalty Pharma plc | 33.25B | 0.47% | 3,536,433 | 2.54B |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.60B | 4.44% | 2,734,454 | 4.80B |
| 8 | ROIV | Roivant Sciences Ltd. | 24.89B | 0.03% | 5,856,685 | 8.26M |
| 9 | INCY | Incyte Corporation | 24.28B | -0.66% | 1,792,522 | 5.82B |
| 10 | BNTX | BioNTech SE | 23.16B | 0.91% | 1,700,644 | 3.03B |
| 11 | MRNA | Moderna, Inc. | 22.46B | -1.29% | 5,172,624 | 2.23B |
| 12 | INSM | Insmed Incorporated | 21.46B | 0.27% | 4,899,561 | 819.56M |
| 13 | GMAB | Genmab A/S | 17.94B | 0.83% | 1,404,184 | 3.90B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 16.98B | -0.02% | 715,213 | 4.60B |
| 15 | ASND | Ascendis Pharma A/S | 16.10B | -0.16% | 486,238 | 998.25M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 16.03B | -0.10% | 2,522,730 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 14.25B | 1.25% | 4,202,012 | 2.44B |
| 18 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.28B | -2.99% | 1,703,421 | 669.50M |
| 19 | CORT | Corcept Therapeutics Incorporated | 11.97B | 0.81% | 846,681 | 830.81M |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.88B | 1.29% | 349,535 | 1.28B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 11.58B | -1.33% | 1,685,604 | 3.24B |
| 22 | TECH | Bio-Techne Corporation | 11.22B | -0.12% | 1,778,396 | 1.21B |
| 23 | AXSM | Axsome Therapeutics, Inc. | 10.95B | 0.32% | 665,339 | 708.24M |
| 24 | ABVX | ABIVAX Société Anonyme | 10.86B | 0.16% | 659,994 | 5.67M |
| 25 | SMMT | Summit Therapeutics Inc. | 10.79B | -1.67% | 3,154,602 | - |
| 26 | CYTK | Cytokinetics, Incorporated | 10.71B | 0.31% | 1,594,077 | 105.82M |
| 27 | APGE | Apogee Therapeutics, Inc. | 10.08B | 0.03% | 1,961,056 | - |
| 28 | HALO | Halozyme Therapeutics, Inc. | 9.91B | 0.43% | 1,262,636 | 1.51B |
| 29 | KRYS | Krystal Biotech, Inc. | 9.64B | 0.31% | 324,536 | 440.48M |
| 30 | SYRE | Spyre Therapeutics, Inc. | 9.20B | -0.56% | 1,036,948 | - |
| 31 | IONS | Ionis Pharmaceuticals, Inc. | 9.01B | -1.60% | 2,122,261 | 874.09M |
| 32 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.91B | 0.17% | 2,866,831 | 42.16M |
| 33 | PRAX | Praxis Precision Medicines, Inc. | 8.90B | 2.95% | 274,901 | 7.46M |
| 34 | PTGX | Protagonist Therapeutics, Inc. | 8.83B | 1.11% | 430,508 | 281.99M |
| 35 | KYMR | Kymera Therapeutics, Inc. | 8.68B | 1.04% | 586,211 | 105.00M |
| 36 | IMVT | Immunovant, Inc. | 8.11B | -0.20% | 1,521,883 | - |
| 37 | PCVX | Vaxcyte, Inc. | 8.07B | 2.25% | 886,273 | - |
| 38 | IBRX | ImmunityBio, Inc. | 7.68B | 4.32% | 11,506,544 | 165.79M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.62B | 4.66% | 1,087,049 | 239.92M |
| 40 | COGT | Cogent Biosciences, Inc. | 7.22B | -1.33% | 1,880,969 | - |
| 41 | TGTX | TG Therapeutics, Inc. | 7.07B | 2.34% | 2,841,326 | 799.54M |
| 42 | ERAS | Erasca, Inc. | 6.46B | 1.31% | 3,104,113 | - |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 6.45B | 1.40% | 882,174 | 618.07M |
| 44 | CGON | CG Oncology, Inc. | 6.39B | 1.43% | 922,742 | 5.07M |
| 45 | DNTH | Dianthus Therapeutics, Inc. | 6.29B | 1.90% | 1,051,823 | 1.90M |
| 46 | BLTE | Belite Bio, Inc | 6.24B | 0.78% | 141,931 | - |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 6.22B | 0.45% | 617,251 | 7.50M |
| 48 | LGND | Ligand Pharmaceuticals Incorporated | 5.99B | 0.59% | 197,036 | 274.48M |
| 49 | TVTX | Travere Therapeutics, Inc. | 5.92B | 12.03% | 6,006,649 | 591.33M |
| 50 | DFTX | Definium Therapeutics, Inc. | 5.89B | 4.89% | 1,561,547 | - |
| 51 | ORKA | Oruka Therapeutics, Inc. | 5.86B | -0.96% | 639,813 | - |
| 52 | PTCT | PTC Therapeutics, Inc. | 5.78B | 0.16% | 1,102,511 | 1.01B |
| 53 | SRRK | Scholar Rock Holding Corporation | 5.74B | 0.17% | 1,053,064 | - |
| 54 | CRSP | CRISPR Therapeutics AG | 5.07B | -1.17% | 1,619,586 | 13.39M |
| 55 | ACAD | ACADIA Pharmaceuticals Inc. | 4.96B | 6.08% | 4,549,093 | 1.14B |
| 56 | DYN | Dyne Therapeutics, Inc. | 4.89B | 0.77% | 2,152,580 | - |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.84B | 0.63% | 1,734,425 | - |
| 58 | MANE | Veradermics, Incorporated | 4.65B | 3.78% | 935,345 | - |
| 59 | CAI | Caris Life Sciences, Inc. | 4.65B | 2.17% | 6,766,326 | 989.61M |
| 60 | CELC | Celcuity Inc. | 4.53B | 0.46% | 771,948 | - |
| 61 | PBLS | Parabilis Medicines, Inc. | 4.44B | -2.79% | 268,884 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 4.29B | 0.77% | 1,505,651 | 10.68M |
| 63 | ELVN | Enliven Therapeutics, Inc. | 4.17B | -2.31% | 1,724,187 | - |
| 64 | TNGX | Tango Therapeutics, Inc. | 4.16B | -1.94% | 1,861,478 | 56.99M |
| 65 | VKTX | Viking Therapeutics, Inc. | 3.91B | 1.73% | 1,960,705 | - |
| 66 | DNLI | Denali Therapeutics Inc. | 3.88B | 1.03% | 1,094,202 | - |
| 67 | LEGN | Legend Biotech Corporation | 3.69B | -0.42% | 1,703,017 | 1.14B |
| 68 | GPCR | Structure Therapeutics Inc. | 3.59B | 1.79% | 713,407 | - |
| 69 | TLX | Telix Pharmaceuticals Limited | 3.53B | 1.26% | 99,237 | 803.79M |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.48B | -3.82% | 1,040,584 | 117.00M |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 3.48B | -0.19% | 1,004,922 | 234.13M |
| 72 | ALMS | Alumis Inc. | 3.46B | - | 630,541 | 8.40M |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 3.39B | 4.11% | 2,448,788 | 463.98M |
| 74 | CLDX | Celldex Therapeutics, Inc. | 3.22B | 5.15% | 788,849 | 865.00K |
| 75 | MBX | MBX Biosciences, Inc. | 3.21B | -4.55% | 487,475 | - |
| 76 | NAMS | NewAmsterdam Pharma Company N.V. | 3.21B | -0.47% | 1,652,555 | 7.12M |
| 77 | QURE | uniQure N.V. | 3.07B | 1.28% | 799,948 | 18.67M |
| 78 | IRON | Disc Medicine, Inc. | 3.03B | 1.43% | 272,288 | - |
| 79 | IMNM | Immunome, Inc. | 2.89B | 1.84% | 1,092,402 | 4.02M |
| 80 | KOD | Kodiak Sciences Inc. | 2.72B | 1.68% | 525,216 | - |
| 81 | BEAM | Beam Therapeutics Inc. | 2.70B | -4.51% | 2,056,904 | 156.04M |
| 82 | ATAI | AtaiBeckley Inc. | 2.67B | 0.56% | 9,548,974 | 3.49M |
| 83 | TRVI | Trevi Therapeutics, Inc. | 2.65B | -0.53% | 1,501,886 | - |
| 84 | TARS | Tarsus Pharmaceuticals, Inc. | 2.64B | 0.29% | 354,602 | 535.08M |
| 85 | NRIX | Nurix Therapeutics, Inc. | 2.61B | 1.74% | 1,343,966 | 36.77M |
| 86 | NKTR | Nektar Therapeutics | 2.47B | 0.45% | 581,026 | 55.63M |
| 87 | PGEN | Precigen, Inc. | 2.47B | 5.51% | 16,936,790 | 85.72M |
| 88 | RARE | Ultragenyx Pharmaceutical Inc. | 2.45B | -3.41% | 2,642,397 | 717.00M |
| 89 | MLYS | Mineralys Therapeutics, Inc. | 2.37B | 1.32% | 504,315 | - |
| 90 | KLRA | Kailera Therapeutics, Inc. | 2.35B | 0.33% | 296,700 | - |
| 91 | COAG | Hemab Therapeutics Holdings, Inc. | 2.34B | 7.67% | 353,424 | - |
| 92 | PHVS | Pharvaris N.V. | 2.34B | -1.33% | 386,923 | - |
| 93 | SLS | SELLAS Life Sciences Group, Inc. | 2.33B | 0.42% | 5,763,731 | - |
| 94 | VRDN | Viridian Therapeutics, Inc. | 2.33B | 1.10% | 1,666,705 | 70.92M |
| 95 | VCEL | Vericel Corporation | 2.32B | -2.11% | 468,797 | 306.30M |
| 96 | URGN | UroGen Pharma Ltd. | 2.27B | 16.31% | 2,480,806 | 188.73M |
| 97 | PVLA | Palvella Therapeutics, Inc. | 2.23B | 1.92% | 147,304 | - |
| 98 | HRMY | Harmony Biosciences Holdings, Inc. | 2.23B | -1.39% | 1,282,153 | 959.90M |
| 99 | NUVB | Nuvation Bio Inc. | 2.22B | -1.09% | 5,493,676 | 143.05M |
| 100 | VERA | Vera Therapeutics, Inc. | 2.18B | 1.34% | 3,213,732 | - |
| 101 | ADMA | ADMA Biologics, Inc. | 2.15B | 3.93% | 3,799,237 | 512.28M |
| 102 | SION | Sionna Therapeutics, Inc. | 2.14B | -5.21% | 757,882 | - |
| 103 | TSHA | Taysha Gene Therapies, Inc. | 2.07B | 4.19% | 2,180,843 | 7.47M |
| 104 | ZLAB | Zai Lab Limited | 2.06B | -0.65% | 195,278 | 453.28M |
| 105 | STOK | Stoke Therapeutics, Inc. | 2.06B | 0.82% | 635,011 | 27.59M |
| 106 | BHVN | Biohaven Ltd. | 2.05B | -0.87% | 1,431,631 | - |
| 107 | RAPP | Rapport Therapeutics, Inc. | 2.03B | 0.57% | 210,106 | 20.00M |
| 108 | ZBIO | Zenas BioPharma, Inc. | 2.01B | 1.40% | 410,965 | 10.00M |
| 109 | GHRS | GH Research PLC | 2.00B | 0.03% | 232,201 | - |
| 110 | NBTX | Nanobiotix S.A. | 1.99B | 0.38% | 88,348 | 38.27M |
| 111 | AUPH | Aurinia Pharmaceuticals Inc. | 1.95B | 1.74% | 1,024,761 | 298.30M |
| 112 | MESO | Mesoblast Limited | 1.95B | 1.08% | 80,709 | 65.38M |
| 113 | IOVA | Iovance Biotherapeutics, Inc. | 1.94B | -0.46% | 15,595,084 | 285.61M |
| 114 | DMRA | Damora Therapeutics, Inc. | 1.90B | 2.70% | 607,286 | - |
| 115 | AGIO | Agios Pharmaceuticals, Inc. | 1.89B | 0.32% | 915,634 | 98.34M |
| 116 | FBRX | Forte Biosciences, Inc. | 1.87B | 0.07% | 1,366,853 | - |
| 117 | OCUL | Ocular Therapeutix, Inc. | 1.87B | -1.05% | 1,599,918 | 52.06M |
| 118 | GENB | Generate Biomedicines, Inc. | 1.86B | 1.47% | 440,912 | 30.30M |
| 119 | FTRE | Fortrea Holdings Inc. | 1.81B | 5.89% | 1,911,407 | 2.68B |
| 120 | KARD | Kardigan, Inc. | 1.81B | -1.17% | 171,240 | - |
| 121 | ABCL | AbCellera Biologics Inc. | 1.81B | -2.79% | 4,625,461 | 66.17M |
| 122 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | 4.40% | 3,774,995 | 252.25M |
| 123 | OBX | Obsidian Therapeutics, Inc. | 1.76B | -16.15% | 18,366 | - |
| 124 | SEPN | Septerna, Inc. | 1.75B | -0.56% | 442,958 | 72.26M |
| 125 | LKFT | Lakefront Biotherapeutics NV | 1.74B | -1.40% | 319,781 | 1.20B |
| 126 | BCAX | Bicara Therapeutics Inc. | 1.70B | -0.80% | 818,323 | - |
| 127 | RXRX | Recursion Pharmaceuticals, Inc. | 1.70B | -4.23% | 17,458,815 | 54.86M |
| 128 | IMCR | Immunocore Holdings plc | 1.69B | 0.15% | 518,503 | 412.81M |
| 129 | ZYME | Zymeworks Inc. | 1.68B | 3.12% | 488,367 | 81.26M |
| 130 | SRPT | Sarepta Therapeutics, Inc. | 1.68B | -2.81% | 3,106,385 | 1.97B |
| 131 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.65B | -0.31% | 1,199,374 | 204.73M |
| 132 | TRAX | First Tracks Biotherapeutics, Inc. | 1.64B | 2.04% | 939,932 | - |
| 133 | ANAB | AnaptysBio, Inc. | 1.63B | -0.25% | 316,608 | 232.39M |
| 134 | AAPG | Ascentage Pharma Group International | 1.57B | 0.99% | 4,617 | 82.08M |
| 135 | MAZE | Maze Therapeutics, Inc. | 1.54B | 0.72% | 254,326 | 20.00M |
| 136 | VIR | Vir Biotechnology, Inc. | 1.54B | -0.65% | 1,452,638 | 65.50M |
| 137 | TYRA | Tyra Biosciences, Inc. | 1.53B | -20.97% | 2,741,841 | - |
| 138 | NTLA | Intellia Therapeutics, Inc. | 1.53B | -3.09% | 4,734,413 | 66.09M |
| 139 | INVA | Innoviva, Inc. | 1.51B | -1.68% | 702,931 | 440.00M |
| 140 | XNCR | Xencor, Inc. | 1.47B | -0.40% | 825,984 | 104.97M |
| 141 | MLTX | MoonLake Immunotherapeutics | 1.45B | -2.12% | 579,212 | - |
| 142 | AVBP | ArriVent BioPharma, Inc. | 1.43B | -2.79% | 500,411 | - |
| 143 | ABSI | Absci Corporation | 1.42B | -0.94% | 2,101,157 | 1.84M |
| 144 | AVLN | Avalyn Pharma Inc. | 1.42B | 4.13% | 188,930 | - |
| 145 | SVRA | Savara Inc. | 1.40B | 1.85% | 1,602,380 | - |
| 146 | ORIC | ORIC Pharmaceuticals, Inc. | 1.34B | -4.01% | 2,138,462 | - |
| 147 | IMTX | Immatics N.V. | 1.34B | 4.16% | 676,478 | 43.00M |
| 148 | GLUE | Monte Rosa Therapeutics, Inc. | 1.32B | -2.92% | 1,980,109 | 42.95M |
| 149 | MNKD | MannKind Corporation | 1.31B | 3.54% | 6,833,549 | 393.63M |
| 150 | LBRX | LB Pharmaceuticals Inc | 1.29B | 0.07% | 317,743 | - |
| 151 | JBIO | Jade Biosciences, Inc. | 1.29B | 1.78% | 1,265,111 | - |
| 152 | NVAX | Novavax, Inc. | 1.27B | 0.52% | 3,632,834 | 596.34M |
| 153 | AKTS | Aktis Oncology, Inc. | 1.25B | -0.83% | 248,419 | 8.28M |
| 154 | INBX | Inhibrx Biosciences, Inc. | 1.23B | 0.43% | 142,140 | 1.30M |
| 155 | ARDX | Ardelyx, Inc. | 1.21B | -2.00% | 3,109,709 | 427.68M |
| 156 | VOR | Vor Biopharma Inc. | 1.21B | 0.09% | 723,689 | - |
| 157 | DRTS | Alpha Tau Medical Ltd. | 1.20B | 1.38% | 343,962 | - |
| 158 | SPTX | Seaport Therapeutics, Inc. | 1.20B | 3.87% | 119,425 | - |
| 159 | CRVS | Corvus Pharmaceuticals, Inc. | 1.17B | -0.07% | 738,924 | - |
| 160 | WVE | Wave Life Sciences Ltd. | 1.17B | -1.17% | 1,837,192 | 65.37M |
| 161 | MGTX | MeiraGTx Holdings plc | 1.16B | 2.12% | 420,147 | 79.76M |
| 162 | ANRO | Alto Neuroscience, Inc. | 1.09B | -0.71% | 248,771 | - |
| 163 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.09B | -1.61% | 3,974,293 | 69.64M |
| 164 | CGEM | Cullinan Therapeutics, Inc. | 1.08B | 0.34% | 465,623 | - |
| 165 | IVA | Inventiva S.A. | 1.06B | 4.66% | 707,505 | 7.94M |
| 166 | APMD | Apnimed, Inc. | 1.06B | 3.11% | 486,272 | 120.15M |
| 167 | SANA | Sana Biotechnology, Inc. | 1.05B | 3.24% | 3,008,840 | - |
| 168 | GERN | Geron Corporation | 1.05B | 21.64% | 36,076,753 | 204.56M |
| 169 | EYPT | EyePoint, Inc. | 1.03B | 4.97% | 2,450,066 | 2.79M |
| 170 | OLMA | Olema Pharmaceuticals, Inc. | 1.01B | -1.53% | 722,413 | - |
| 171 | ODTX | Odyssey Therapeutics, Inc. | 1.00B | 4.66% | 131,529 | 1.06M |
| 172 | AVTX | Avalo Therapeutics, Inc. | 996.69M | 1.67% | 734,417 | 59.00K |
| 173 | REPL | Replimune Group, Inc. | 993.30M | -0.76% | 2,862,133 | - |
| 174 | JANX | Janux Therapeutics, Inc. | 975.75M | 0.25% | 546,026 | 13.73M |
| 175 | ATTO | Attovia Therapeutics, Inc. | 942.34M | 28.82% | 4,906,956 | 1.35M |
| 176 | OMER | Omeros Corporation | 915.55M | -2.24% | 1,116,888 | 9.89M |
| 177 | ABUS | Arbutus Biopharma Corporation | 912.62M | 4.52% | 1,704,821 | 191.45M |
| 178 | ACRS | Aclaris Therapeutics, Inc. | 888.26M | 6.35% | 5,676,002 | 8.37M |
| 179 | ANNX | Annexon, Inc. | 879.83M | 0.75% | 1,770,792 | - |
| 180 | TBPH | Theravance Biopharma, Inc. | 875.90M | 0.12% | 400,374 | 109.78M |
| 181 | SLDB | Solid Biosciences Inc. | 859.47M | 1.28% | 876,399 | - |
| 182 | DSGN | Design Therapeutics, Inc. | 849.23M | 2.80% | 472,059 | - |
| 183 | DBVT | DBV Technologies S.A. | 830.24M | 3.87% | 407,285 | 5.04M |
| 184 | KURA | Kura Oncology, Inc. | 816.72M | -2.85% | 1,281,183 | 71.64M |
| 185 | MNPR | Monopar Therapeutics Inc. | 798.70M | 0.65% | 182,730 | - |
| 186 | AURA | Aura Biosciences, Inc. | 791.95M | 0.42% | 314,811 | - |
| 187 | SGP | SpyGlass Pharma, Inc. | 791.70M | -1.78% | 65,081 | - |
| 188 | DRUG | Bright Minds Biosciences Inc. | 766.86M | 3.43% | 117,281 | - |
| 189 | CADL | Candel Therapeutics, Inc. | 766.41M | -0.48% | 750,661 | - |
| 190 | PHAR | Pharming Group N.V. | 758.20M | 4.04% | 5,278 | 366.48M |
| 191 | RIGL | Rigel Pharmaceuticals, Inc. | 756.16M | 4.60% | 748,870 | 276.79M |
| 192 | TENX | Tenax Therapeutics, Inc. | 747.53M | -5.57% | 2,249,924 | - |
| 193 | CTMX | CytomX Therapeutics, Inc. | 729.30M | 0.90% | 2,030,829 | 35.54M |
| 194 | OCS | Oculis Holding AG | 728.88M | 0.67% | 579,268 | 1.40M |
| 195 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 717.76M | 1.01% | 147,366 | - |
| 196 | NGNE | Neurogene Inc. | 716.97M | 4.56% | 167,580 | 925.00K |
| 197 | CLYM | Climb Bio, Inc. | 714.04M | -0.72% | 1,103,808 | - |
| 198 | AGMB | AgomAb Therapeutics NV | 705.23M | -2.78% | 29,059 | - |
| 199 | GYRE | Gyre Therapeutics, Inc. | 694.58M | 1.30% | 35,221 | 117.05M |
| 200 | ACHV | Achieve Life Sciences, Inc. | 683.71M | 2.94% | 898,238 | - |
| 201 | IMMX | Immix Biopharma, Inc. | 679.15M | 2.25% | 1,316,775 | - |
| 202 | CBIO | Crescent Biopharma, Inc. | 674.97M | -3.72% | 184,345 | 11.88M |
| 203 | ALLO | Allogene Therapeutics, Inc. | 673.05M | 2.63% | 5,056,037 | 22.00K |
| 204 | PHAT | Phathom Pharmaceuticals, Inc. | 653.71M | -2.60% | 1,652,437 | 239.66M |
| 205 | HELP | Cybin Inc. | 652.69M | 13.47% | 2,813,160 | - |
| 206 | RGNX | REGENXBIO Inc. | 647.88M | 1.94% | 1,521,969 | 87.82M |
| 207 | FTH | Faeth Therapeutics, Inc. | 633.90M | -3.57% | 383,417 | - |
| 208 | NVCT | Nuvectis Pharma, Inc. | 627.52M | -4.18% | 220,115 | - |
| 209 | ZVRA | Zevra Therapeutics, Inc. | 622.48M | 0.10% | 780,892 | 136.07M |
| 210 | DNA | Ginkgo Bioworks Holdings, Inc. | 612.09M | - | 988,996 | 151.40M |
| 211 | MDXG | MiMedx Group, Inc. | 606.36M | -2.58% | 1,468,633 | 355.17M |
| 212 | ALT | Altimmune, Inc. | 589.26M | -1.30% | 3,163,967 | 36.00K |
| 213 | MPLT | MapLight Therapeutics, Inc. | 585.87M | -0.15% | 886,828 | - |
| 214 | CRMD | CorMedix Inc. | 581.33M | -1.46% | 615,454 | 400.05M |
| 215 | CTNM | Contineum Therapeutics, Inc. | 574.47M | -3.96% | 247,732 | - |
| 216 | RLMD | Relmada Therapeutics, Inc. | 570.60M | -0.55% | 827,270 | - |
| 217 | STTK | Shattuck Labs, Inc. | 565.14M | -6.94% | 967,131 | 1.00M |
| 218 | ARTV | Artiva Biotherapeutics, Inc. | 563.14M | 4.70% | 548,568 | 251.00K |
| 219 | TECX | Tectonic Therapeutic, Inc. | 557.77M | 1.34% | 125,942 | - |
| 220 | PRME | Prime Medicine, Inc. | 556.30M | 3.36% | 3,145,003 | 4.03M |
| 221 | ARVN | Arvinas, Inc. | 549.24M | -6.67% | 1,571,496 | 316.70M |
| 222 | FDMT | 4D Molecular Therapeutics, Inc. | 537.40M | 0.19% | 664,783 | 88.24M |
| 223 | ZURA | Zura Bio Limited | 535.79M | -0.88% | 852,084 | - |
| 224 | SGMT | Sagimet Biosciences Inc. | 533.54M | 8.14% | 2,137,332 | - |
| 225 | SPRY | ARS Pharmaceuticals, Inc. | 532.27M | 0.75% | 2,542,225 | 98.99M |
| 226 | SLN | Silence Therapeutics plc | 530.91M | 0.36% | 452,234 | 839.00K |
| 227 | ANL | Adlai Nortye Ltd. | 522.80M | 0.54% | 111,494 | 5.00M |
| 228 | EIKN | Eikon Therapeutics, Inc. | 517.02M | -0.10% | 276,772 | - |
| 229 | VSTM | Verastem, Inc. | 515.82M | 1.03% | 1,554,979 | 49.59M |
| 230 | ASMB | Assembly Biosciences, Inc. | 510.82M | 0.36% | 113,346 | 71.10M |
| 231 | AUTL | Autolus Therapeutics plc | 505.67M | -2.56% | 1,576,982 | 92.62M |
| 232 | PROK | ProKidney Corp. | 504.44M | 2.45% | 605,945 | 889.00K |
| 233 | QTTB | Q32 Bio Inc. | 490.81M | 2.04% | 651,333 | 53.74M |
| 234 | OVID | Ovid Therapeutics Inc. | 489.00M | 3.15% | 2,253,502 | 7.12M |
| 235 | RZLT | Rezolute, Inc. | 488.90M | -5.84% | 1,374,261 | - |
| 236 | VALN | Valneva SE | 488.51M | 1.75% | 48,839 | 180.25M |
| 237 | IKT | Inhibikase Therapeutics, Inc. | 469.01M | -1.64% | 1,108,441 | 1.00 |
| 238 | EVMN | Evommune, Inc. | 468.96M | -0.69% | 637,368 | 10.00M |
| 239 | KYTX | Kyverna Therapeutics, Inc. | 464.48M | -1.80% | 576,960 | - |
| 240 | SLBT | SL Science Holding Limited | 452.55M | -9.09% | 96,033 | 3.27M |
| 241 | PRLD | Prelude Therapeutics Incorporated | 450.27M | 0.44% | 158,272 | 16.72M |
| 242 | SCTX | Scribe Therapeutics Inc. | 448.97M | 7.89% | 266,556 | 36.28M |
| 243 | PRTA | Prothena Corporation plc | 444.48M | - | 489,490 | 57.94M |
| 244 | CABA | Cabaletta Bio, Inc. | 441.88M | -2.17% | 10,228,201 | - |
| 245 | BNTC | Benitec Biopharma Inc. | 435.96M | 1.36% | 95,223 | - |
| 246 | OCGN | Ocugen, Inc. | 433.31M | -2.29% | 6,304,968 | 4.47M |
| 247 | LRMR | Larimar Therapeutics, Inc. | 427.97M | -0.24% | 1,281,051 | - |
| 248 | VTVT | vTv Therapeutics Inc. | 426.76M | 7.27% | 102,668 | 36.84M |
| 249 | EPRX | Eupraxia Pharmaceuticals Inc. | 422.67M | -0.61% | 99,697 | - |
| 250 | EDIT | Editas Medicine, Inc. | 422.02M | -0.72% | 1,938,283 | 47.01M |
| 251 | STRO | Sutro Biopharma, Inc. | 415.92M | -2.22% | 159,118 | 99.61M |
| 252 | PBYI | Puma Biotechnology, Inc. | 406.69M | 2.44% | 237,976 | 227.18M |
| 253 | CCCC | C4 Therapeutics, Inc. | 400.25M | 0.28% | 2,556,298 | 34.86M |
| 254 | XFOR | X4 Pharmaceuticals, Inc. | 391.43M | -3.26% | 372,581 | 9.01M |
| 255 | ABEO | Abeona Therapeutics Inc. | 387.57M | -0.29% | 720,721 | 14.54M |
| 256 | ENTA | Enanta Pharmaceuticals, Inc. | 384.42M | -0.75% | 230,043 | 69.21M |
| 257 | RCKT | Rocket Pharmaceuticals, Inc. | 382.18M | 1.74% | 1,981,534 | - |
| 258 | AVIR | Atea Pharmaceuticals, Inc. | 380.13M | 1.06% | 258,841 | - |
| 259 | PALI | Palisade Bio, Inc. | 367.99M | 2.42% | 1,979,672 | - |
| 260 | UPB | Upstream Bio, Inc. | 366.79M | -0.74% | 917,129 | 3.32M |
| 261 | FENC | Fennec Pharmaceuticals Inc. | 365.43M | 4.06% | 153,806 | 51.00M |
| 262 | DMAC | DiaMedica Therapeutics Inc. | 359.13M | 1.91% | 130,709 | - |
| 263 | IPSC | Century Therapeutics, Inc. | 353.50M | -2.49% | 833,748 | 109.16M |
| 264 | ZNTL | Zentalis Pharmaceuticals, Inc. | 352.37M | 1.43% | 578,304 | 26.87M |
| 265 | LXEO | Lexeo Therapeutics, Inc. | 349.42M | 0.91% | 910,642 | - |
| 266 | AGEN | Agenus Inc. | 348.17M | -6.27% | 1,457,059 | 123.87M |
| 267 | CMPX | Compass Therapeutics, Inc. | 340.37M | -4.55% | 4,253,427 | 850.00K |
| 268 | CUVL | Clinuvel Pharmaceuticals Limited | 331.92M | -4.91% | 1,650 | 64.24M |
| 269 | VCRE | Vicore Pharma Holding AB (publ) | 331.75M | -1.46% | 840 | 370.61K |
| 270 | LYEL | Lyell Immunopharma, Inc. | 329.58M | -1.10% | 484,688 | 31.00K |
| 271 | IRD | Opus Genetics, Inc. | 312.10M | 1.89% | 872,101 | 11.98M |
| 272 | VNDA | Vanda Pharmaceuticals Inc. | 306.09M | -4.50% | 1,601,205 | 215.72M |
| 273 | FATE | Fate Therapeutics, Inc. | 303.05M | 1.17% | 3,386,999 | 6.32M |
| 274 | NMRA | Neumora Therapeutics, Inc. | 298.31M | 0.63% | 655,936 | - |
| 275 | AVXL | Anavex Life Sciences Corp. | 296.55M | 1.59% | 1,166,254 | - |
| 276 | OABI | OmniAb, Inc. | 294.29M | 1.50% | 441,839 | 28.94M |
| 277 | SABS | SAB Biotherapeutics, Inc. | 288.27M | -2.08% | 284,283 | 114.70K |
| 278 | SLGL | Sol-Gel Technologies Ltd. | 287.67M | 4.14% | 66,812 | 18.47M |
| 279 | FULC | Fulcrum Therapeutics, Inc. | 287.64M | -0.79% | 1,254,136 | 80.00M |
| 280 | FHTX | Foghorn Therapeutics Inc. | 286.52M | 0.41% | 158,839 | 28.22M |
| 281 | LCTX | Lineage Cell Therapeutics, Inc. | 284.20M | 1.79% | 693,055 | 14.78M |
| 282 | IMRX | Immuneering Corporation | 284.02M | -0.23% | 508,604 | - |
| 283 | TTRX | Turn Therapeutics Inc. | 280.90M | -0.95% | 32,887 | - |
| 284 | ADAG | Adagene Inc. | 279.49M | 16.21% | 435,741 | 7.67M |
| 285 | PRQR | ProQR Therapeutics N.V. | 278.01M | 7.65% | 1,311,046 | 15.73M |
| 286 | BCYC | Bicycle Therapeutics plc | 277.15M | 0.76% | 287,679 | 61.21M |
| 287 | ELDN | Eledon Pharmaceuticals, Inc. | 265.92M | -1.43% | 771,141 | - |
| 288 | IFRX | InflaRx N.V. | 260.71M | -0.56% | 710,044 | 33.82K |
| 289 | ALXO | ALX Oncology Holdings Inc. | 258.36M | -2.54% | 594,155 | - |
| 290 | SRZN | Surrozen, Inc. | 254.85M | -0.23% | 333,454 | 7.49M |
| 291 | TRDA | Entrada Therapeutics, Inc. | 254.40M | -2.49% | 591,549 | 4.69M |
| 292 | OBIO | Orchestra BioMed Holdings, Inc. | 252.70M | -1.17% | 148,276 | 32.72M |
| 293 | MGNX | MacroGenics, Inc. | 247.90M | - | 263,567 | 157.08M |
| 294 | RNAC | Cartesian Therapeutics, Inc. | 245.34M | 3.60% | 113,228 | 1.78M |
| 295 | CNXU | Conexeu Sciences Inc. | 240.56M | -0.99% | 166,031 | - |
| 296 | NAGE | Niagen Bioscience, Inc. | 236.24M | -14.70% | 1,826,335 | 129.08M |
| 297 | CAPR | Capricor Therapeutics, Inc. | 227.59M | -5.76% | 3,678,169 | 11.13M |
| 298 | ACIU | AC Immune SA | 227.17M | 0.88% | 145,223 | 21.67M |
| 299 | TARA | Protara Therapeutics, Inc. | 224.82M | -0.25% | 480,801 | - |
| 300 | CHRS | Coherus Oncology, Inc. | 223.66M | -2.03% | 999,321 | 50.94M |
| 301 | WHWK | Whitehawk Therapeutics, Inc. | 218.90M | -1.69% | 599,376 | 7.15M |
| 302 | CGEN | Compugen Ltd. | 215.97M | -4.20% | 238,853 | 74.00M |
| 303 | GLSI | Greenwich LifeSciences, Inc. | 211.22M | 0.28% | 81,370 | - |
| 304 | ANTX | AN2 Therapeutics, Inc. | 210.33M | -1.68% | 145,949 | - |
| 305 | CLLS | Cellectis S.A. | 208.22M | 0.72% | 4,274 | 75.11M |
| 306 | CAMP | Camp4 Therapeutics Corporation | 208.22M | -3.61% | 86,193 | 3.93M |
| 307 | GALT | Galectin Therapeutics Inc. | 203.50M | 3.52% | 354,965 | - |
| 308 | NERV | Minerva Neurosciences, Inc. | 202.66M | 7.67% | 116,418 | - |
| 309 | RNA | Atrium Therapeutics, Inc. | 200.82M | 1.73% | 171,861 | 36.68M |
| 310 | PYXS | Pyxis Oncology, Inc. | 198.30M | -0.95% | 668,768 | 13.86M |
| 311 | KROS | Keros Therapeutics, Inc. | 198.17M | -2.49% | 335,052 | 15.01M |
| 312 | PLX | Protalix BioTherapeutics, Inc. | 196.59M | 2.95% | 538,929 | 76.38M |
| 313 | HUMA | Humacyte, Inc. | 196.51M | 2.33% | 2,054,974 | 2.02M |
| 314 | DTIL | Precision BioSciences, Inc. | 192.74M | 2.61% | 266,581 | 45.07M |
| 315 | OTLK | Outlook Therapeutics, Inc. | 192.61M | 7.27% | 5,197,048 | 333.14K |
| 316 | IMUX | Immunic, Inc. | 190.84M | -0.28% | 276,512 | - |
| 317 | NBP | NovaBridge Biosciences | 189.66M | -0.61% | 152,860 | - |
| 318 | VYGR | Voyager Therapeutics, Inc. | 187.31M | -0.80% | 582,214 | 36.49M |
| 319 | ACOG | Alpha Cognition Inc. | 185.52M | -4.70% | 92,430 | 10.83M |
| 320 | MDWD | MediWound Ltd. | 182.37M | -0.77% | 65,588 | 14.48M |
| 321 | TNXP | Tonix Pharmaceuticals Holding Corp. | 179.49M | 0.45% | 261,480 | 17.56M |
| 322 | NGEN | NervGen Pharma Corp. | 178.77M | 1.20% | 597,250 | - |
| 323 | IVVD | Invivyd, Inc. | 178.06M | 5.44% | 3,877,434 | 55.87M |
| 324 | ARCT | Arcturus Therapeutics Holdings Inc. | 177.93M | 0.64% | 450,359 | 54.71M |
| 325 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 177.31M | 1.81% | 235,971 | - |
| 326 | ORMP | Oramed Pharmaceuticals Inc. | 176.80M | -3.14% | 162,434 | 2.00M |
| 327 | ARMP | Armata Pharmaceuticals, Inc. | 172.54M | 0.43% | 103,380 | 5.20M |
| 328 | TNYA | Tenaya Therapeutics, Inc. | 170.28M | 5.81% | 3,438,024 | 1.34M |
| 329 | OKUR | OnKure Therapeutics, Inc. | 168.05M | 1.46% | 250,222 | - |
| 330 | IPHA | Innate Pharma S.A. | 166.35M | -0.84% | 1,841 | 10.57M |
| 331 | KRRO | Korro Bio, Inc. | 166.28M | 1.58% | 105,841 | 3.84M |
| 332 | ALEC | Alector, Inc. | 165.43M | -3.25% | 392,304 | 18.42M |
| 333 | LENZ | LENZ Therapeutics, Inc. | 165.24M | 4.36% | 964,154 | 20.99M |
| 334 | AARD | Aardvark Therapeutics, Inc. | 164.06M | 4.01% | 195,929 | - |
| 335 | ABOS | Acumen Pharmaceuticals, Inc. | 161.79M | - | 298,079 | - |
| 336 | CRBU | Caribou Biosciences, Inc. | 159.68M | 2.55% | 1,115,904 | 11.20M |
| 337 | YDES | YD Bio Limited | 158.22M | -3.02% | 23,953 | 510.36K |
| 338 | NKTX | Nkarta, Inc. | 157.40M | -2.65% | 806,972 | - |
| 339 | MIST | Milestone Pharmaceuticals Inc. | 155.78M | -2.14% | 600,805 | 1.78M |
| 340 | MOLN | Molecular Partners AG | 152.39M | - | 191 | 856.30K |
| 341 | MENS | Jyong Biotech Ltd. | 152.18M | 0.49% | 54,448 | - |
| 342 | INDP | Indaptus Therapeutics, Inc. | 150.61M | -2.21% | 113,942 | - |
| 343 | CBUS | Cibus, Inc. | 147.32M | 0.52% | 167,373 | 4.29M |
| 344 | CNTN | Canton Strategic Holdings, Inc. | 146.53M | -0.52% | 650,988 | - |
| 345 | UNCY | Unicycive Therapeutics, Inc. | 143.27M | 1.16% | 764,291 | - |
| 346 | ENTX | Entera Bio Ltd. | 138.51M | -2.09% | 308,460 | 42.00K |
| 347 | EQ | Equillium, Inc. | 138.47M | -3.10% | 322,301 | 4.39M |
| 348 | CNTB | Connect Biopharma Holdings Limited | 137.26M | 5.31% | 528,339 | 233.00K |
| 349 | KZIA | Kazia Therapeutics Limited | 137.12M | -2.52% | 233,026 | 1.27M |
| 350 | PEPG | PepGen Inc. | 136.96M | 2.59% | 668,203 | - |
| 351 | HURA | TuHURA Biosciences, Inc. | 133.10M | - | 132,925 | - |
| 352 | CDXS | Codexis, Inc. | 131.80M | 1.40% | 781,155 | 78.09M |
| 353 | SPRB | Spruce Biosciences, Inc. | 128.28M | 0.76% | 27,925 | 697.00K |
| 354 | NRXP | NRx Pharmaceuticals, Inc. | 128.04M | 0.16% | 685,886 | 2.29M |
| 355 | TLSA | Tiziana Life Sciences Ltd | 128.01M | 2.32% | 984,973 | - |
| 356 | PMN | ProMIS Neurosciences, Inc. | 120.88M | -0.66% | 46,442 | - |
| 357 | ENGN | enGene Therapeutics Inc. | 120.58M | 0.56% | 156,071 | - |
| 358 | SEER | Seer, Inc. | 120.41M | -0.90% | 155,614 | 15.17M |
| 359 | VANI | Vivani Medical, Inc. | 119.00M | -1.43% | 87,393 | - |
| 360 | NAUT | Nautilus Biotechnology, Inc. | 118.35M | -5.61% | 871,376 | 190.00K |
| 361 | ANIX | Anixa Biosciences, Inc. | 116.02M | - | 182,072 | - |
| 362 | CUE | Cue Biopharma, Inc. | 111.94M | 0.19% | 128,722 | 32.73M |
| 363 | GNLX | Genelux Corporation | 111.47M | -10.99% | 950,185 | 8.00K |
| 364 | GUTS | Fractyl Health, Inc. | 108.67M | - | 1,440,863 | 3.00K |
| 365 | COYA | Coya Therapeutics, Inc. | 106.73M | -0.44% | 99,655 | 7.94M |
| 366 | RANI | Rani Therapeutics Holdings, Inc. | 106.36M | -4.88% | 746,305 | 3.17M |
| 367 | PLYX | Polaryx Therapeutics, Inc. | 106.05M | 0.45% | 42,882 | - |
| 368 | YARW | Yarrow Bioscience, Inc. | 105.56M | -0.68% | 25,968 | - |
| 369 | BDTX | Black Diamond Therapeutics, Inc. | 102.57M | 0.56% | 384,096 | 70.00M |
| 370 | KLRS | Kalaris Therapeutics, Inc. | 99.69M | -3.01% | 26,396 | - |
| 371 | PTHS | Pelthos Therapeutics Inc. | 99.19M | 6.89% | 59,712 | 27.70M |
| 372 | ICCC | ImmuCell Corporation | 97.25M | -2.89% | 15,131 | 29.93M |
| 373 | ALDX | Aldeyra Therapeutics, Inc. | 96.51M | 3.23% | 822,587 | - |
| 374 | ACET | Adicet Bio, Inc. | 96.19M | -0.54% | 43,366 | - |
| 375 | HRTX | Heron Therapeutics, Inc. | 95.55M | -1.31% | 1,320,960 | 150.71M |
| 376 | ONCY | Oncolytics Biotech Inc. | 95.15M | -1.64% | 431,717 | - |
| 377 | CGTX | Cognition Therapeutics, Inc. | 94.87M | 7.49% | 655,444 | - |
| 378 | VRCA | Verrica Pharmaceuticals Inc. | 94.66M | 1.85% | 12,009 | 37.16M |
| 379 | FBIO | Fortress Biotech, Inc. | 92.68M | 2.57% | 702,311 | 66.16M |
| 380 | BMEA | Biomea Fusion, Inc. | 91.10M | 2.44% | 397,037 | - |
| 381 | NTHI | NeOnc Technologies Holdings, Inc. | 90.77M | 2.04% | 17,640 | 39.99K |
| 382 | PYPD | PolyPid Ltd. | 88.20M | 3.37% | 134,789 | - |
| 383 | GOSS | Gossamer Bio, Inc. | 86.87M | -2.09% | 8,005,629 | 55.54M |
| 384 | RLYB | Rallybio Corporation | 85.51M | 1.13% | 34,347 | 858.00K |
| 385 | ATHE | Alterity Therapeutics Limited | 85.16M | -0.55% | 1,973 | 4.43M |
| 386 | MAIA | MAIA Biotechnology, Inc. | 85.12M | 2.94% | 275,998 | - |
| 387 | NRXS | NeurAxis, Inc. | 84.09M | -3.14% | 43,674 | 4.28M |
| 388 | OKYO | OKYO Pharma Limited | 82.39M | -4.27% | 66,197 | - |
| 389 | TELO | Telomir Pharmaceuticals, Inc. | 81.15M | 2.61% | 74,651 | - |
| 390 | ANVS | Annovis Bio, Inc. | 79.55M | - | 1,100,208 | - |
| 391 | ATRA | Atara Biotherapeutics, Inc. | 76.95M | -2.17% | 32,523 | 23.14M |
| 392 | GANX | Gain Therapeutics, Inc. | 76.78M | 2.27% | 297,495 | - |
| 393 | ELTX | Elicio Therapeutics, Inc. | 74.81M | 0.95% | 346,071 | - |
| 394 | INO | Inovio Pharmaceuticals, Inc. | 74.23M | 2.10% | 2,289,257 | 65.34K |
| 395 | CSBR | Champions Oncology, Inc. | 73.64M | -2.75% | 14,563 | 59.43M |
| 396 | SPRO | Spero Therapeutics, Inc. | 72.96M | 2.44% | 574,906 | 61.19M |
| 397 | ELOX | Eloxx Pharmaceuticals, Inc. | 72.17M | -2.98% | 58,554 | - |
| 398 | LONA | LeonaBio, Inc. | 72.14M | -0.52% | 7,830 | - |
| 399 | OSTX | OS Therapies Incorporated | 71.26M | -1.84% | 242,508 | - |
| 400 | ACRV | Acrivon Therapeutics, Inc. | 70.19M | 5.13% | 318,790 | - |
| 401 | IBIO | iBio, Inc. | 69.55M | -4.11% | 304,807 | 300.00K |
| 402 | XBIT | XBiotech Inc. | 68.90M | 0.89% | 35,311 | - |
| 403 | ALPS | Alps Group Inc | 66.98M | 1.54% | 7,429 | 3.74M |
| 404 | CING | Cingulate Inc. | 66.54M | 0.82% | 131,714 | - |
| 405 | MNOV | MediciNova, Inc. | 65.46M | 2.31% | 13,668 | 596.64K |
| 406 | CRDF | Cardiff Oncology, Inc. | 65.29M | 2.81% | 628,629 | 525.00K |
| 407 | IMA | ImageneBio, Inc. | 65.19M | 1.23% | 7,948 | 800.00K |
| 408 | PLRX | Pliant Therapeutics, Inc. | 65.02M | - | 152,760 | - |
| 409 | CNTX | Context Therapeutics Inc. | 63.67M | 11.45% | 3,340,588 | - |
| 410 | BOLD | Boundless Bio, Inc. | 62.90M | 3.51% | 527,365 | - |
| 411 | PMVP | PMV Pharmaceuticals, Inc. | 62.40M | - | 137,648 | - |
| 412 | HYFT | MindWalk Holdings Corp. | 62.02M | -2.94% | 108,764 | 11.43M |
| 413 | DWTX | Dogwood Therapeutics, Inc. | 61.54M | 2.23% | 14,669 | - |
| 414 | RNTX | Rein Therapeutics Inc. | 61.11M | -6.46% | 1,101,076 | - |
| 415 | INKT | MiNK Therapeutics, Inc. | 58.29M | 5.69% | 15,392 | - |
| 416 | XLO | Xilio Therapeutics, Inc. | 54.50M | 0.22% | 6,088 | 53.48M |
| 417 | ATYR | aTyr Pharma, Inc. | 51.87M | -0.04% | 457,976 | 190.00K |
| 418 | TCRX | TScan Therapeutics, Inc. | 50.97M | 5.91% | 298,715 | 9.14M |
| 419 | INMB | INmune Bio Inc. | 50.51M | -0.52% | 491,221 | 50.00K |
| 420 | EXOZ | eXoZymes, Inc. | 49.56M | 17.75% | 9,083 | -700.00 |
| 421 | TIL | Instil Bio, Inc. | 49.24M | 0.41% | 9,175 | - |
| 422 | IMMP | Immutep Limited | 48.86M | -0.33% | 154,307 | 5.28M |
| 423 | MCRB | Seres Therapeutics, Inc. | 48.47M | -4.67% | 141,628 | 1.88M |
| 424 | MREO | Mereo BioPharma Group plc | 48.44M | -5.77% | 1,143,904 | 500.00K |
| 425 | RNXT | RenovoRx, Inc. | 47.81M | 1.92% | 316,710 | 1.49M |
| 426 | FLNA | Filana Therapeutics, Inc. | 46.37M | -3.67% | 174,133 | - |
| 427 | IBO | Impact BioMedical Inc. | 46.36M | -2.27% | 30,879 | 39.00K |
| 428 | EDSA | Edesa Biotech, Inc. | 45.97M | -3.54% | 31,373 | - |
| 429 | VRXA | Veraxa Biotech AG | 45.90M | 1.11% | 100,431 | - |
| 430 | MGX | Metagenomi Therapeutics, Inc. | 45.74M | 0.41% | 77,194 | 22.33M |
| 431 | KPTI | Karyopharm Therapeutics Inc. | 43.29M | -2.55% | 2,376,614 | 151.12M |
| 432 | RADX | Radiopharm Theranostics Limited | 42.84M | -4.79% | 76,879 | 10.86M |
| 433 | HYPD | Hyperion DeFi, Inc. | 41.38M | - | 216,432 | 1.04M |
| 434 | PDSB | PDS Biotechnology Corporation | 40.56M | 0.93% | 171,625 | - |
| 435 | BYSI | BeyondSpring Inc. | 40.12M | -1.43% | 26,974 | 1.88M |
| 436 | CRVO | CervoMed Inc. | 38.01M | 0.36% | 269,053 | 2.09M |
| 437 | APLM | Apollomics, Inc. | 37.95M | -1.71% | 419,489 | 8.84M |
| 438 | VERU | Veru Inc. | 37.40M | -1.69% | 89,781 | 16.89M |
| 439 | LTRN | Lantern Pharma Inc. | 35.72M | 1.82% | 52,537 | - |
| 440 | DYAI | Dyadic International, Inc. | 35.33M | -10.23% | 477,132 | 3.81M |
| 441 | ENLV | Enlivex Ltd. | 35.03M | 3.32% | 286,677 | - |
| 442 | GRCE | Grace Therapeutics, Inc. | 34.83M | -1.83% | 648,062 | - |
| 443 | NTRB | Nutriband Inc. | 34.40M | -0.70% | 14,076 | 1.80M |
| 444 | SER | Serina Therapeutics, Inc. | 33.44M | 4.21% | 35,277 | 130.00K |
| 445 | NNVC | NanoViricides, Inc. | 32.58M | -5.92% | 245,916 | - |
| 446 | LITS | Lite Strategy, Inc. | 32.51M | 1.18% | 93,190 | - |
| 447 | ESLA | Estrella Immunopharma, Inc. | 32.15M | 6.11% | 99,548 | - |
| 448 | GNTA | Genenta Science S.p.A. | 31.38M | 4.72% | 24,282 | - |
| 449 | BCTX | BriaCell Therapeutics Corp. | 30.60M | 3.86% | 216,079 | - |
| 450 | ALGS | Aligos Therapeutics, Inc. | 29.33M | -0.21% | 71,826 | 4.71M |
| 451 | TVGN | Tevogen Inc. | 28.90M | -2.14% | 12,541 | - |
| 452 | KYNB | Kyntra Bio, Inc. | 28.30M | 0.43% | 7,315 | 7.44M |
| 453 | QNCX | Quince Therapeutics, Inc. | 28.24M | 5.36% | 42,765 | - |
| 454 | ACTU | Actuate Therapeutics, Inc. | 27.04M | 0.89% | 176,614 | - |
| 455 | CVM | CEL-SCI Corporation | 26.57M | 11.76% | 404,416 | - |
| 456 | ABVC | ABVC BioPharma, Inc. | 25.52M | -5.61% | 114,079 | 797.92K |
| 457 | IGC | IGC Pharma, Inc. | 25.22M | 1.61% | 208,052 | 1.11M |
| 458 | EVAX | Evaxion A/S | 24.85M | 1.02% | 9,589 | 7.53M |
| 459 | ATNM | Actinium Pharmaceuticals, Inc. | 23.49M | -7.57% | 349,559 | 90.00K |
| 460 | BRNS | Barinthus Biotherapeutics plc | 23.29M | 0.96% | 10,446 | 14.97M |
| 461 | LGVN | Longeveron Inc. | 22.97M | -2.02% | 229,303 | 1.22M |
| 462 | CTXR | Citius Pharmaceuticals, Inc. | 21.44M | 25.45% | 5,177,431 | 5.61M |
| 463 | NEUP | Neuphoria Therapeutics Inc. | 21.35M | 1.54% | 40,901 | -13.27K |
| 464 | CELU | Celularity Inc. | 21.25M | 4.38% | 10,142 | 26.55M |
| 465 | ALLR | Allarity Therapeutics, Inc. | 21.16M | 1.53% | 108,106 | 345.00K |
| 466 | PLRZ | Polyrizon Ltd. | 21.06M | 10.29% | 27,079 | - |
| 467 | ATOS | Atossa Therapeutics, Inc. | 20.58M | 3.46% | 36,764 | - |
| 468 | CLRB | Cellectar Biosciences, Inc. | 20.14M | -1.56% | 24,405 | - |
| 469 | DARE | Daré Bioscience, Inc. | 20.07M | - | 57,279 | 1.16M |
| 470 | SKYE | Skye Bioscience, Inc. | 19.74M | -2.31% | 107,838 | - |
| 471 | HOWL | Werewolf Therapeutics, Inc. | 19.54M | -3.04% | 274,634 | 21.00M |
| 472 | NCEL | NewcelX Ltd. | 19.17M | 3.19% | 5,971 | - |
| 473 | NRSN | NeuroSense Therapeutics Ltd. | 19.15M | 4.21% | 293,902 | - |
| 474 | MRKR | Marker Therapeutics, Inc. | 19.01M | -7.32% | 103,526 | 3.55M |
| 475 | NXTC | NextCure, Inc. | 18.96M | -9.17% | 230,247 | - |
| 476 | PLUR | Pluri Inc. | 18.77M | 11.54% | 61,148 | 1.08M |
| 477 | TVRD | Tvardi Therapeutics, Inc. | 18.76M | -1.48% | 335,423 | - |
| 478 | QNTM | Quantum BioPharma Ltd. | 18.49M | 1.05% | 91,441 | - |
| 479 | JSPR | Jasper Therapeutics, Inc. | 18.48M | -0.84% | 336,421 | - |
| 480 | GRDX | GridAI Technologies Corp. | 18.43M | 0.73% | 215,019 | - |
| 481 | LPCN | Lipocine Inc. | 17.89M | 1.97% | 56,199 | 1.57M |
| 482 | PTN | Palatin Technologies, Inc. | 15.80M | -0.87% | 8,102 | 12.88M |
| 483 | OSRH | OSR Health, Inc. | 15.52M | -4.08% | 192,413 | 2.63M |
| 484 | BIVI | BioVie Inc. | 15.39M | 11.48% | 247,942 | - |
| 485 | CYCN | Cyclerion Therapeutics, Inc. | 15.06M | 1.14% | 39,074 | 1.90M |
| 486 | KTTA | Pasithea Therapeutics Corp. | 15.04M | -2.17% | 216,299 | - |
| 487 | HIND | Vyome Holdings, Inc. | 15.02M | -1.38% | 10,173 | 152.72K |
| 488 | PASG | Passage Bio, Inc. | 14.79M | -0.43% | 12,004 | - |
| 489 | MLEC | Moolec Science SA | 14.77M | -1.39% | 931 | 7.83M |
| 490 | COCP | Cocrystal Pharma, Inc. | 14.06M | 4.06% | 69,044 | 225.00K |
| 491 | TPST | Tempest Therapeutics, Inc. | 13.54M | 3.05% | 99,209 | - |
| 492 | AKTX | Akari Therapeutics, Plc | 13.13M | -3.72% | 21,848 | - |
| 493 | BLRX | BioLineRx Ltd. | 13.09M | -1.56% | 4,643 | 1.40M |
| 494 | KALA | KALA BIO, Inc. | 13.03M | -5.65% | 40,377 | - |
| 495 | CMMB | Chemomab Therapeutics Ltd. | 12.60M | 4.17% | 97,761 | - |
| 496 | PBM | Psyence Biomedical Ltd. | 12.55M | 3.13% | 61,535 | - |
| 497 | PHIO | Phio Pharmaceuticals Corp. | 12.43M | 0.94% | 54,580 | - |
| 498 | BIOT | Instinct Bio Technical Company Holdings Inc. | 12.37M | 0.21% | 648,350 | - |
| 499 | VTGN | Vistagen Therapeutics, Inc. | 12.19M | -1.00% | 5,543,761 | 1.27M |
| 500 | ICU | SeaStar Medical Holding Corporation | 12.14M | -5.33% | 83,384 | 1.44M |